Bremelanotide vs L-692,429

Head-to-head comparison of Bremelanotide (Bremelanotide (PT-141), cyclic melanocortin receptor agonist) and L-692,429 (L-692,429) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyBremelanotideL-692,429
CategorySexual HealthGrowth Hormone
Full NameBremelanotide (PT-141), cyclic melanocortin receptor agonistL-692,429
Molecular Weight1025.2 DaN/A
Half-Lifeabout 2.7 hunknown / study-dependent
Amino Acids7N/A
Typical Dose1.75 mg0.03-0.1 mg/kg
RouteSubcutaneousOral
Purity≥98%≥98%
Studies Count20030
Research StatusClinicalPre-clinical

Bremelanotide Benefits

  • increases sexual desire
  • supports arousal
  • may improve erectile response
  • on-demand use

L-692,429 Benefits

  • potent GHSR agonism
  • oral bioactivity in models
  • validates ghrelin pathway
  • useful research probe

Bremelanotide Dosing

1.75 mg subcutaneous PRN|administer about 45 minutes before activity|max 1 dose per 24 hours

L-692,429 Dosing

0.03-0.1 mg/kg in early studies|single oral or short-course research dosing|serial GH sampling recommended

Bremelanotide Side Effects

  • nausea
  • flushing
  • headache
  • transient blood pressure increase

L-692,429 Side Effects

  • increased appetite
  • glucose intolerance
  • transient prolactin changes

Research Overview

Bremelanotide

Human studies and approval data support meaningful effects on sexual desire in women, with a central mechanism involving melanocortin signaling. It is one of the most clinically relevant peptides in this category and is commonly used as the reference compound for PT-141-type research.

L-692,429

L-692,429 was important in early GH secretagogue research because it showed that nonpeptide molecules could trigger robust GH release. It remains a classic tool compound for studying receptor-mediated GH pulsatility and appetite signaling.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Bremelanotide stacks with:

Kisspeptin-54Melanotan-II

L-692,429 stacks with:

Receptor assaysEndocrine studies
melanocortinlibidoerectile-functionapprovedtool-compoundgh-secretagogueghrelin-pathway